An evidence-based educational news feed curating peer-reviewed research and clinical guidance, with plain-language editorial review and evidence-grounded Q&A. All items link to primary sources.
Healthcare professional? Professional Room →Evidence Radar active · 66 validated items in archive
MenopauseDigest monitors, validates, and interprets the evidence shaping the menopause transition. Our Evidence Radar continuously scans clinical research, guidance, and reporting—so you can see what is established, what is emerging, and what remains uncertain.
MenopauseDigest is not a destination for answers. It is a place for understanding.
Why MenopauseDigest Exists
For women navigating perimenopause and menopause, information arrives from every direction. Social media offers confidence and certainty, often without accountability. Medical research offers rigor and depth, but in language that assumes clinical training and time most people do not have.
MenopauseDigest was created in response to that failure. We exist to provide Intelligence for the Transition—not opinions, not prescriptions, and not products. We use technology and disciplined editorial standards to gather, interrogate, and translate menopause research so women can understand what is known, what is uncertain, and what questions are worth asking.
Read Our Story →Trust Framework
Understanding requires trust, and trust requires standards. MenopauseDigest is deliberately separated from sponsored content, commercial influence, unverified claims, and algorithm-driven health feeds. These are the standards that make the rest of the platform meaningful.
Non-Commercial Feed
No sponsorships, no affiliate deals, no commercial influence shaping what we cover.
Pure Editorial
Independent editorial judgment. No paid placements, no advertorials, no hidden incentives.
Direct Sourcing
Every item links to its primary source so you can verify the evidence yourself.
Local Privacy
Search history, reflections, and translations stay on your device—never on our servers.
Evidence Classification Framework
Classification is not about organizing content. It is about helping you judge how much weight any finding deserves. Every item is tagged by domain and by epistemic status so you can see, at a glance, how settled or how provisional the evidence really is.
Epistemic Status
Established / Validated
Findings supported by replication and consensus clinical guidance—evidence you can lean on with confidence.
Recent / Emerging
New studies and developing signals worth knowing about, but not yet settled. We flag them so you can weigh the uncertainty.
Domains
Medical
Clinical research, hormone therapy, symptoms, and treatment evidence.
Wellness
Lifestyle, nutrition, exercise, and behavioral interventions.
Relational
Partnership, family, and the relational dimensions of the transition.
Society
Workplace, policy, and cultural framing of midlife health.
Evidence Archive
The archive is not a feed and not a ranking. Each item is classified by the maturity of its evidence so you can see, at a glance, what deserves confidence and what deserves continued observation. The archive answers what is happening. The Editorial Series help answer what it means.
Established / Validated
Supported by replication, consensus guidance, or enduring research.
Recent / Emerging
Important and noteworthy, but still developing. Weigh with care.
Established / Validated
The FDA is hosting a public workshop to address the scientific evidence and significant knowledge gaps regarding testosterone therapy for menopausal women. The meeting aims to inform future research and drug development by examining current off-label use and long-term safety concerns.
fda.gov
Last reviewed Sep 4, 2026
Established / Validated
A large-scale study of over 183,000 postmenopausal women found that hormone replacement therapy (HRT) use for at least one year is associated with a 10% lower risk of all-cause dementia. The protective association was most pronounced among women who underwent surgical menopause, carried the APOE ε4 gene, or initiated therapy between ages 46 and 56.
alz-journals.onlinelibrary.wiley.com
Last reviewed Aug 30, 2026
Established / Validated
Researchers analyzed data from the Doetinchem Cohort Study to determine how accurately women recall their age at natural menopause over three decades. The study found that determining a precise age was difficult for many due to hormone use and surgery, and recall consistency declined significantly as time passed.
sciencedirect.com
Last reviewed Aug 27, 2026
Established / Validated
A five-year retrospective study of 294 men at two Australian hospitals found that functional causes, such as obesity and sleep apnea, are the most common reasons for low testosterone. The research indicates that many cases are related to reversible metabolic and lifestyle factors rather than structural diseases of the reproductive system.
pubmed.ncbi.nlm.nih.gov
Government Health Org
Last reviewed Aug 23, 2026
Established / Validated
Menopause is a natural stage of aging marked by the permanent cessation of menstrual periods and a significant decline in estrogen and progesterone. The transition, or perimenopause, typically begins between ages 45 and 55 and involves various physical and hormonal changes.
nia.nih.gov
Government Health Org
Last reviewed Aug 22, 2026
Established / Validated
The Menopause Society has received significant funding to enhance menopause education, including a $5 million grant for digital innovation and a $10 million grant for outreach in underserved areas. These initiatives aim to scale training for healthcare professionals and provide evidence-based resources for patients worldwide.
menopause.org
Last reviewed Aug 22, 2026
Established / Validated
This clinical study evaluates the effectiveness of a specialized menopause education program designed for women with visual impairments. The research utilizes an audio-described format to provide health information and assess its impact on participants' knowledge and quality of life.
clinicaltrials.gov
Last reviewed Aug 21, 2026
Established / Validated
A propensity-matched study analyzed 2,688 male patients to determine if preoperative testosterone replacement therapy (TRT) affects recovery after hip replacement surgery. The research compared surgical and medical complication rates between TRT users and non-users over a two-year period.
sciencedirect.com
Last reviewed Aug 17, 2026
Established / Validated
A large-scale cohort study examined the relationship between estrogen-only hormone therapy and Alzheimer's disease outcomes using two independent datasets. The research analyzed autopsy data, fluid biomarkers, and clinical diagnoses to determine if hormone use influenced dementia risk.
pubmed.ncbi.nlm.nih.gov
Government Health Org
Last reviewed Aug 15, 2026
Showing 9 of 66 validated items.
View Full Evidence Library →Editorial Series — The Interpretive Layer
Where the Evidence Radar surfaces and validates new findings, the Editorial Series sit alongside it as the interpretive layer—translating the evidence into the questions, decisions, and lived realities of the transition.
Editorial Series
"This is not a relationship problem. It is a biological transition that the relational system was never designed to absorb without interpretation."
Read Series →Editorial Series
"This is not a communication problem. It is a relational system operating beyond its functional capacity."
Read Series →Editorial Series
"This is not simply emotional overwhelm. It is the accumulation of invisible relational labor that is no longer being absorbed by the system."
Read Series →Editorial Series
"This is not a relationship breakdown. It is a stable system under sustained stress losing its ability to regulate itself."
Read Series →Editorial Series
"This is not a phase to fix or optimize. It is a reorganization of identity that changes how a person experiences themselves and their relationships."
Read Series →Validated Evidence & Health Literacy
Enter the URL of any menopause-related news or medical article. Our radar will audit it for scientific citations, editorial standards, and marketing bias.
What this tool does — and does not — evaluate
MenopauseDigest Brief
Subscribe to the MenopauseDigest Brief (free)
Periodic summaries of new menopause research and reporting, evaluated for credibility and explained in real-world context.
No products. No promotions. No advice—just clarity.
Questions submitted here may inform future coverage or evidence-grounded Q&A. We cannot respond individually and do not provide medical advice.
